Teva Launches Generic Prevpac Kit

Teva announced the launch of Lansoprazole Delayed-Release Capsules, Amoxicillin Capsules, and Clarithromycin Tablets, the generic version of Takeda's Prevpac Kit.

RELATED: Gastrohepatic Disorders Resource Center

Prevpac is a combination of a proton pump inhibitor, a penicillin antibiotic, and a macrolide antibiotic, indicated for the eradication of Helicobacter pylori to reduce risk of duodenal ulcer recurrence. Lansoprazole, clarithromycin and/or amoxicillin have been shown to be active against most strains of Helicobacter pylori in vitro and in duodenal ulcer disease.

Teva's Lansoprazole Delayed-Release Capsules, Amoxicillin Capsules, and Clarithromycin Tablets are available in a 30mg/500mg/500mg strength in 14x8 cards.

For more information call (888) 838-2872 or visit TevaGenerics.com